Published in Am J Med on November 01, 1979
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol (1997) 6.61
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.64
Severe acquired immunodeficiency in European homosexual men. Br Med J (Clin Res Ed) (1982) 1.59
Histogenesis of Kaposi's sarcoma in patients with and without acquired immune deficiency syndrome (AIDS). J Clin Pathol (1986) 1.34
Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci U S A (1998) 1.12
Kaposi's sarcoma in a patient after renal transplantation. Postgrad Med J (1983) 1.06
Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation (1989) 1.02
Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers. Front Microbiol (2012) 0.97
The acquired immune deficiency syndrome (AIDS)--a multidisciplinary enigma. West J Med (1984) 0.96
Activation of human herpesvirus replication by apoptosis. J Virol (2013) 0.90
The viral etiology of AIDS-associated malignancies. Adv Pharmacol (2008) 0.89
Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus. Mol Cancer Ther (2007) 0.86
A history of Kaposi's sarcoma. J R Soc Med (1986) 0.83
Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi sarcoma. J Clin Pathol (1996) 0.81
Molecular analysis of human herpesvirus 8 by using single nucleotide polymorphisms in open reading frame 26. J Clin Microbiol (2003) 0.81
The Acquired Immunodeficiency Syndrome: current status. Yale J Biol Med (1983) 0.80
Nasopharyngeal carcinoma: an EBV-associated tumour not significantly influenced by HIV-induced immunosuppression. The AIDS/Cancer Working Group. Br J Cancer (1996) 0.78
Differences in androgens of HIV positive patients with and without Kaposi sarcoma. J Clin Pathol (1995) 0.77
Ultrastructural study of pseudo-Kaposi's sarcoma (Bluefarb-Stewart type). Arch Dermatol Res (1989) 0.75
Neoplasia in AIDS. Bull N Y Acad Med (1987) 0.75
Kaposi's sarcoma in a patient with rheumatoid arthritis and polymyositis treated with corticosteroids. West J Med (1988) 0.75
Hepatitis B immune globulin as treatment of CMV infections in patients with AIDS. J Natl Med Assoc (1986) 0.75
De novo and recurrent Kaposi's Sarcoma after renal transplantation in two patients taking everolimus. Hippokratia (2008) 0.75
Current concepts of the immunological function of the thymus. Physiol Rev (1967) 8.37
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol (1996) 7.02
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer (2000) 4.96
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol (1999) 2.97
Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol (1983) 2.71
Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res (2000) 2.65
ABO-incompatible heart transplantation in infants. N Engl J Med (2001) 2.01
Guidelines for radiation oncology registrar training. Royal North Shore Hospital. Australas Radiol (1996) 1.94
Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer (1997) 1.85
The effects of thymus and other lymphoid organs enclosed in millipore diffusion chambers on neonatally thymectomized mice. J Exp Med (1965) 1.78
Canadian Hemodialysis Morbidity Study. Am J Kidney Dis (1992) 1.72
Increased plasma tumor necrosis factor concentration in severe rhabdomyolysis is not reduced by continuous arteriovenous hemodialysis. Crit Care Med (1992) 1.70
Hyperglycemia-induced hyponatremia: metabolic considerations in calculation of serum sodium depression. Can Med Assoc J (1975) 1.66
Immune complexes induce selective release of lysosomal hydrolases from macrophages. Nature (1974) 1.64
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol (1999) 1.63
Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res (1996) 1.58
The nature of the renal adaptation to chronic hypocapnia. J Clin Invest (1972) 1.56
Restriction of the capacity to respond to two antigens by single precursors of antibody-producing cells in culture. J Exp Med (1969) 1.55
Quality-of-life assessment: patient compliance with questionnaire completion. J Natl Cancer Inst (1992) 1.55
Some physical and radiobiological properties of immunologically reactive mouse spleen cells. J Exp Med (1970) 1.55
Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res (1997) 1.54
A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial. Br J Dermatol (2011) 1.50
Sites of ammonia addition to tubular fluid in rats with chronic metabolic acidosis. Kidney Int (1981) 1.45
The benefits and side effects of ramped hypertonic sodium dialysis. J Am Soc Nephrol (1996) 1.43
Report card on renal transplantation. CMAJ (2000) 1.39
Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada. Ann Intern Med (1987) 1.38
The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care (1997) 1.37
Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. J Clin Oncol (1987) 1.31
Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life. Qual Life Res (1998) 1.31
VP-16 and cisplatin as first-line therapy for small-cell lung cancer. J Clin Oncol (1985) 1.30
Studies on the pathogenesis of type I (distal) renal tubular acidosis as revealed by the urinary PCO2 tensions. J Clin Invest (1974) 1.30
Clinical practice guidelines for initiation of dialysis. Canadian Society of Nephrology. J Am Soc Nephrol (1999) 1.26
Radiotherapy of chondrosarcoma of bone. Cancer (1980) 1.26
Mesenchymal chondrosarcoma: a report of 17 cases. Clin Orthop Relat Res (1981) 1.26
Canadian cancer care: organizational models. Ann Intern Med (1986) 1.25
Research on health-related quality of life: dissemination into practical applications. Qual Life Res (1994) 1.25
Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck (1999) 1.25
Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int (2000) 1.24
Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat Med (1998) 1.22
Thymic control of cellular differentiation in the immunological system. Proc Soc Exp Biol Med (1968) 1.21
Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis (1997) 1.13
Ameloblastoma of the jaw. A reappraisal of the role of megavoltage irradiation. Cancer (1984) 1.12
HL-A antigens and survival in Hodgkin's disease. Lancet (1971) 1.11
Radiotherapy for unusual tumors of the head and neck. J Otolaryngol (1984) 1.10
Histopathological study of radionecrosis in laryngeal carcinoma. Laryngoscope (1982) 1.09
Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer. J Clin Oncol (1985) 1.08
Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer. J Clin Oncol (1994) 1.07
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol (2011) 1.06
Interpretation of the serum potassium concentration in metabolic acidosis. Clin Invest Med (1979) 1.06
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1998) 1.05
Differentiation of thymus-derived cells from precursors in mouse bone marrow. J Exp Med (1973) 1.04
Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Ann Oncol (2007) 1.04
Management of T3 glottic cancer. Arch Otolaryngol (1980) 1.02
Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8. J Clin Oncol (2000) 1.02
The Karnofsky Performance Status Scale re-examined: a cross-validation with the EORTC-C30. Qual Life Res (1994) 1.02
Successful renal transplantation in patients with T-cell reactivity to donor. Lancet (1982) 1.01
DTIC therapy in metastatic malignant melanoma: a simplified dose schedule. Cancer Treat Rep (1981) 1.01
Radiotherapy of extramedullary plasmacytoma of the head and neck. Clin Radiol (1981) 1.01
Radiation therapy of cerebral metastases: a randomized prospective clinical trial. Int J Radiat Oncol Biol Phys (1978) 1.00
Immune Reactivity in Mice Thymectomized Soon after Birth: Normal Response after Pregnancy. Science (1965) 0.99
Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study. Br J Dermatol (2000) 0.99
The treatment of glomus tumors in the temporal bone by megavoltage radiation. Cancer (1984) 0.97
Radiotherapy for malignant melanoma: a re-appraisal. Cancer Treat Rev (1981) 0.96
Percutaneous needle biopsy of the transplanted kidney: technique and complications. Am J Kidney Dis (1989) 0.96
"Spontaneous" progressive multifocal leukoencephalopathy. Immunologic aspects. Ann Intern Med (1972) 0.96
Postirradiation sarcoma of bone: a perspective. Cancer (1979) 0.95
Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer. J Clin Oncol (1991) 0.94
A humoral thymus mechanism responsible for immunologic maturation. Ann N Y Acad Sci (1965) 0.93
Supervoltage irradiation in the management of giant cell tumor of bone. Radiology (1977) 0.93
Tinea capitis: an overview with emphasis on management. Pediatr Dermatol (1999) 0.93
Prognostic significance of thyroid gland involvement in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg (1986) 0.92
The occurrence of mycosis fungoides in two patients with preexisting Hodgkin's disease. Arch Dermatol (1982) 0.92
Second primary respiratory tract malignancies in glottic carcinoma. Cancer (1980) 0.92
Radical external beam radiation therapy for adenocarcinoma of the rectum. Dis Colon Rectum (1983) 0.92
The mixed-leukocyte reaction in man: effect of pools of stimulating cells selected on the basis of crossreacting HL-A specificities. Cell Immunol (1974) 0.92
Lithium-induced impairment of urine acidification. Kidney Int (1976) 0.92
Ammonia addition into the medullary collecting duct of the rat. Kidney Int (1981) 0.91
Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int (1991) 0.91
Management of early supraglottic laryngeal carcinoma by irradiation with surgery in reserve. Arch Otolaryngol (1983) 0.91
Results of a controlled drug trial in membranoproliferative glomerulonephritis. Kidney Int (1985) 0.90
Cutaneous associations of chronic renal failure and dialysis. Int J Dermatol (1986) 0.90
Use of genetically defined nude mice in the study of the mixed leukocyte reaction. J Immunol (1974) 0.90
Second primary respiratory tract malignant neoplasms in supraglottic carcinoma. Arch Otolaryngol (1981) 0.90
Supraglottic laryngeal carcinoma: an analysis of dose-time-volume factors in 410 patients. Int J Radiat Oncol Biol Phys (1983) 0.90
Stimulation of ammonia production and excretion in the rabbit by inorganic phosphate. Study of control mechanisms. J Clin Invest (1976) 0.89
Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol (1986) 0.89
Ten years of experience with vascular complications in renal transplantation. J Urol (1982) 0.89
Results of radical radiation for chondrosarcoma of bone. Radiother Oncol (1983) 0.89
Kaposi's sarcoma complicating corticosteroid therapy for temporal arteritis. Am J Med (1981) 0.89
Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis. J Natl Cancer Inst (1991) 0.89
The influence of graded degrees of chronic hypercapnia on the acute carbon dioxide titration curve. J Clin Invest (1971) 0.89
The treatment of chordomas. Cancer Treat Rev (1982) 0.89
The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized Trial. Int J Radiat Oncol Biol Phys (1988) 0.89
Factors influencing long-term primary cadaveric kidney transplantation--importance of functional renal mass versus avoidance of acute rejections--the Toronto Hospital experience 1985-1997. Clin Transpl (1998) 0.88
Pathogenesis of acidosis in hereditary fructose intolerance. Metabolism (1979) 0.87
Radiotherapy for mucosal melanomas. Int J Radiat Oncol Biol Phys (1982) 0.87
Radiotherapy of Kaposi's sarcoma. Cancer (1978) 0.87